1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 DeRose, E.F. Clarkson, M.W. Gilmore, S.A. Ramsden, D.A. Mueller, G.A. London, R.E. Lee, A.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 46 12100 12110 10.1021/bi7007728 17915942 Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining. 2007 10.2210/pdb2htf/pdb pdb_00002htf 1 SINGLE WAVELENGTH M 1 1.0 11420.022 DNA polymerase mu 2.7.7.7 BRCT domain S20G 1 man polymer Pol Mu no no GTPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL LDISWLTESLGAGQPVPVECRHRLE GTPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL LDISWLTESLGAGQPVPVECRHRLE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample POLM 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2007-02-27 1 1 2008-05-01 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details RCSB Y RCSB 2006-07-25 REL REL structures with the lowest energy 100 11 3D_13C-separated_NOESY 3D_15N-separated_NOESY 50 mM KCl 7.9 ambient 283 K The initial structures were computed using the auto noeassign feature of CYANA 2.1; 1503 NOE distance restraints were assigned, and 147 dihedral angle restraints were used in the calculation. The 20 best CYANA structures were refined in explicit solvent using ARIA 2.0a with the 1506 NOE distance restraints, 147 dihedral angle restraints, 42 H-bond restraints, and 48 residual dipolar coupling restraints. Torsion angle dynamics followed by molecular dynamics refinement in explicit water solvent 1 minimized average structure 1mM polymerase mu BRCT domain, 25 mM d-Tris, 50 mM KCl, 0.02% NaN3, 5 mM DTT, pH 7.9, 90% H2O, 10% D2O 90% H2O/10% D2O Varian collection VNMR 1.1C, VNMRJ 1.1C Delaglio, Grzesiek, Vuister, Zhu, Pfeifer, and Bax processing NMRPipe 2003, 2004 Johnson and Blevins processing NMRView 5.0.4 Guentert, Mumenthaler, Herrmann, and Wuthrich structure solution CYANA 2.1 Habeck, Rieping, Linge, and Nilges refinement ARIA 2.0a 600 Varian INOVA 800 Varian INOVA GLY 20 n 1 GLY 20 A THR 21 n 2 THR 21 A PRO 22 n 3 PRO 22 A PRO 23 n 4 PRO 23 A SER 24 n 5 SER 24 A THR 25 n 6 THR 25 A ARG 26 n 7 ARG 26 A PHE 27 n 8 PHE 27 A PRO 28 n 9 PRO 28 A GLY 29 n 10 GLY 29 A VAL 30 n 11 VAL 30 A ALA 31 n 12 ALA 31 A ILE 32 n 13 ILE 32 A TYR 33 n 14 TYR 33 A LEU 34 n 15 LEU 34 A VAL 35 n 16 VAL 35 A GLU 36 n 17 GLU 36 A PRO 37 n 18 PRO 37 A ARG 38 n 19 ARG 38 A MET 39 n 20 MET 39 A GLY 40 n 21 GLY 40 A ARG 41 n 22 ARG 41 A SER 42 n 23 SER 42 A ARG 43 n 24 ARG 43 A ARG 44 n 25 ARG 44 A ALA 45 n 26 ALA 45 A PHE 46 n 27 PHE 46 A LEU 47 n 28 LEU 47 A THR 48 n 29 THR 48 A GLY 49 n 30 GLY 49 A LEU 50 n 31 LEU 50 A ALA 51 n 32 ALA 51 A ARG 52 n 33 ARG 52 A SER 53 n 34 SER 53 A LYS 54 n 35 LYS 54 A GLY 55 n 36 GLY 55 A PHE 56 n 37 PHE 56 A ARG 57 n 38 ARG 57 A VAL 58 n 39 VAL 58 A LEU 59 n 40 LEU 59 A ASP 60 n 41 ASP 60 A ALA 61 n 42 ALA 61 A CYS 62 n 43 CYS 62 A SER 63 n 44 SER 63 A SER 64 n 45 SER 64 A GLU 65 n 46 GLU 65 A ALA 66 n 47 ALA 66 A THR 67 n 48 THR 67 A HIS 68 n 49 HIS 68 A VAL 69 n 50 VAL 69 A VAL 70 n 51 VAL 70 A MET 71 n 52 MET 71 A GLU 72 n 53 GLU 72 A GLU 73 n 54 GLU 73 A THR 74 n 55 THR 74 A SER 75 n 56 SER 75 A ALA 76 n 57 ALA 76 A GLU 77 n 58 GLU 77 A GLU 78 n 59 GLU 78 A ALA 79 n 60 ALA 79 A VAL 80 n 61 VAL 80 A SER 81 n 62 SER 81 A TRP 82 n 63 TRP 82 A GLN 83 n 64 GLN 83 A GLU 84 n 65 GLU 84 A ARG 85 n 66 ARG 85 A ARG 86 n 67 ARG 86 A MET 87 n 68 MET 87 A ALA 88 n 69 ALA 88 A ALA 89 n 70 ALA 89 A ALA 90 n 71 ALA 90 A PRO 91 n 72 PRO 91 A PRO 92 n 73 PRO 92 A GLY 93 n 74 GLY 93 A CYS 94 n 75 CYS 94 A THR 95 n 76 THR 95 A PRO 96 n 77 PRO 96 A PRO 97 n 78 PRO 97 A ALA 98 n 79 ALA 98 A LEU 99 n 80 LEU 99 A LEU 100 n 81 LEU 100 A ASP 101 n 82 ASP 101 A ILE 102 n 83 ILE 102 A SER 103 n 84 SER 103 A TRP 104 n 85 TRP 104 A LEU 105 n 86 LEU 105 A THR 106 n 87 THR 106 A GLU 107 n 88 GLU 107 A SER 108 n 89 SER 108 A LEU 109 n 90 LEU 109 A GLY 110 n 91 GLY 110 A ALA 111 n 92 ALA 111 A GLY 112 n 93 GLY 112 A GLN 113 n 94 GLN 113 A PRO 114 n 95 PRO 114 A VAL 115 n 96 VAL 115 A PRO 116 n 97 PRO 116 A VAL 117 n 98 VAL 117 A GLU 118 n 99 GLU 118 A CYS 119 n 100 CYS 119 A ARG 120 n 101 ARG 120 A HIS 121 n 102 HIS 121 A ARG 122 n 103 ARG 122 A LEU 123 n 104 LEU 123 A GLU 124 n 105 GLU 124 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ARG 57 A O ARG 38 A N ILE 32 A N ILE 13 A N TYR 33 A N TYR 14 A O HIS 68 A O HIS 49 A N VAL 69 A N VAL 50 A O LEU 100 A O LEU 81 2 A A HB3 HA LEU ARG 100 122 1.18 2 A A HG13 HE1 VAL TRP 69 82 1.25 2 A A O H ARG GLU 122 124 1.60 3 A A O H LEU ALA 47 51 1.55 4 A A HB HA THR ARG 25 57 1.30 5 A A HB HB2 THR ARG 25 57 1.27 6 A A HD1 HD12 HIS LEU 68 100 1.17 7 A A HG13 HE1 VAL TRP 69 82 1.23 8 A A HG13 HE1 VAL TRP 69 82 1.20 8 A A HG HB2 LEU ALA 59 66 1.30 8 A A HB HA THR ARG 25 57 1.35 9 A A HG13 HE1 VAL TRP 69 82 1.28 10 A A HB HB2 THR ARG 25 57 1.28 11 A A HG13 HE1 VAL TRP 69 82 1.23 1 A SER 24 -59.49 86.93 1 A ARG 26 61.89 -82.23 1 A PRO 28 -71.24 -167.47 1 A ALA 61 62.96 166.37 1 A ALA 76 -60.64 -73.09 1 A PRO 92 -55.71 106.27 1 A PRO 97 -69.52 -179.50 1 A PRO 114 -63.74 93.53 1 A LEU 123 -72.24 22.93 2 A PRO 23 -53.49 87.71 2 A PRO 28 -77.25 49.95 2 A PRO 37 -68.93 9.13 2 A ARG 38 -149.38 36.27 2 A LYS 54 -93.29 -60.76 2 A HIS 68 169.77 100.57 2 A PRO 97 -77.44 -167.70 2 A LEU 123 48.79 -25.39 3 A PRO 23 -67.50 66.45 3 A THR 25 -122.41 -120.81 3 A ARG 26 -178.82 -69.10 3 A PRO 37 -71.58 46.68 3 A ARG 38 -174.09 -45.88 3 A MET 39 -83.15 -71.48 3 A ASP 60 -109.76 -161.84 3 A ILE 102 -58.27 -1.17 3 A PRO 114 -68.10 95.13 3 A ARG 122 -86.67 33.26 3 A LEU 123 -56.44 6.67 4 A PRO 23 -40.07 102.29 4 A ARG 26 77.22 -55.34 4 A PRO 28 -84.02 -159.09 4 A MET 39 -171.17 128.60 4 A LYS 54 -96.60 -62.16 4 A ASP 60 -86.31 39.23 4 A PRO 97 -64.98 -166.23 4 A LEU 100 170.98 155.71 4 A ARG 122 -79.05 31.87 4 A LEU 123 -62.37 15.93 5 A PRO 23 -69.55 63.28 5 A ARG 26 -115.01 -78.59 5 A ARG 38 -141.18 43.75 5 A CYS 62 75.70 -36.97 5 A HIS 68 -161.59 105.87 5 A LEU 100 -172.80 -175.02 5 A PRO 114 -66.82 95.31 6 A PRO 37 -74.47 49.15 6 A ARG 38 -175.13 -40.90 6 A HIS 68 157.22 91.55 6 A LEU 100 -172.26 -167.42 6 A ASP 101 -119.15 -165.04 6 A ARG 122 -86.18 34.56 6 A LEU 123 -60.83 6.38 7 A ARG 26 -103.43 -60.21 7 A MET 39 -172.44 -166.43 7 A PRO 114 -64.60 90.80 7 A LEU 123 63.24 -70.13 8 A PRO 23 -55.52 105.51 8 A THR 25 -128.06 -92.62 8 A ARG 26 164.28 -70.24 8 A ASP 60 -78.97 -143.47 8 A CYS 62 58.44 73.62 8 A PRO 97 -60.33 -160.77 8 A ILE 102 -58.38 -6.44 8 A LEU 123 -52.76 83.09 9 A PRO 23 -66.03 63.74 9 A LYS 54 -90.31 -62.21 9 A ASP 60 -77.61 -169.78 9 A THR 67 -156.76 55.12 9 A HIS 68 157.88 95.51 9 A PRO 97 -58.13 -154.67 9 A LEU 100 174.26 -167.72 9 A PRO 114 -65.22 92.26 9 A LEU 123 -49.98 -5.99 10 A PRO 23 -38.03 99.03 10 A ARG 26 89.30 -45.13 10 A ARG 38 69.03 -11.11 10 A CYS 62 74.37 -45.17 10 A PRO 97 -62.58 -175.10 10 A ILE 102 -65.66 55.27 10 A SER 103 -131.20 -31.20 10 A PRO 114 -67.49 99.85 10 A ARG 122 -83.42 32.70 10 A LEU 123 -61.46 24.13 11 A PRO 23 -38.26 116.81 11 A THR 25 50.77 70.75 11 A ASP 60 -149.08 38.91 11 A THR 67 -155.26 42.69 11 A HIS 68 163.95 67.63 11 A PRO 97 -62.67 -159.22 11 A LEU 100 -172.69 -172.41 11 A PRO 114 -67.76 84.99 minimized average The solution structure of the BRCT domain from human polymerase reveals homology with the TdT BRCT domain 1 N N A GLU 36 A GLU 17 HELX_P A MET 39 A MET 20 5 1 4 A GLY 40 A GLY 21 HELX_P A GLY 55 A GLY 36 1 2 16 A SER 75 A SER 56 HELX_P A ALA 90 A ALA 71 1 3 16 A ILE 102 A ILE 83 HELX_P A GLY 112 A GLY 93 1 4 11 TRANSFERASE BRCT domain, alpha-beta-alpha sandwich, TRANSFERASE DPOLM_HUMAN UNP 1 20 Q9NP87 STPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPAL LDISWLTESLGAGQPVPVECRHRLE 21 124 2HTF 21 124 Q9NP87 A 1 2 105 1 cloning artifact GLY 20 2HTF A Q9NP87 UNP 1 4 parallel parallel parallel A ARG 57 A ARG 38 A LEU 59 A LEU 40 A ALA 31 A ALA 12 A LEU 34 A LEU 15 A HIS 68 A HIS 49 A MET 71 A MET 52 A ALA 98 A ALA 79 A ASP 101 A ASP 82 1 P 1